|
|
|
|
| LEADER |
02441nmm a2200409 u 4500 |
| 001 |
EB000364979 |
| 003 |
EBX01000000000000000218031 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
130626 ||| eng |
| 020 |
|
|
|a 9781461458005
|
| 100 |
1 |
|
|a Golightly, Larry K.
|e [editor]
|
| 245 |
0 |
0 |
|a Renal Pharmacotherapy
|h Elektronische Ressource
|b Dosage Adjustment of Medications Eliminated by the Kidneys
|c edited by Larry K Golightly, Isaac Teitelbaum, Tyree H. Kiser, Dimitriy A. Levin, Gerard R. Barber, Michael A. Jones, Nancy M. Stolpman, Katherine S. Lundin
|
| 250 |
|
|
|a 1st ed. 2013
|
| 260 |
|
|
|a New York, NY
|b Springer New York
|c 2013, 2013
|
| 300 |
|
|
|a XXIII, 752 p. 1 illus
|b online resource
|
| 505 |
0 |
|
|a A -- B -- C -- D -- E -- F -- G -- H -- I -- J -- K -- L -- M -- N -- O -- P -- Q -- R -- S -- T -- V.-Z.
|
| 653 |
|
|
|a Drug Resistance
|
| 653 |
|
|
|a Pharmacotherapy
|
| 653 |
|
|
|a Nephrology
|
| 653 |
|
|
|a Internal medicine
|
| 653 |
|
|
|a Nephrology
|
| 653 |
|
|
|a Pharmaceutical technology
|
| 653 |
|
|
|a Drug resistance
|
| 653 |
|
|
|a Pharmacotherapy
|
| 653 |
|
|
|a Pharmaceutical Sciences/Technology
|
| 653 |
|
|
|a Internal Medicine
|
| 653 |
|
|
|a Pharmacology
|
| 653 |
|
|
|a Pharmacology/Toxicology
|
| 700 |
1 |
|
|a Teitelbaum, Isaac
|e [editor]
|
| 700 |
1 |
|
|a Kiser, Tyree H.
|e [editor]
|
| 700 |
1 |
|
|a Levin, Dimitriy A.
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4614-5800-5?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.61
|
| 520 |
|
|
|a As the population of patients with acute or chronic kidney disease grows, healthcare professionals need a resource that optimizes drug effectiveness while minimizing potential toxicity. Renal Pharmacotherapy is a comprehensive listing of dosage recommendations for patients with compromised renal function. This up-to-date and evidence-based reference closes several identified knowledge gaps concerning medications eliminated by the kidneys. Conveniently listed alphabetically by generic drug name, each drug has its own face page featuring typical dosing ranges, alternative dosing adjustments by strata of renal function, specific dosing for dialysis and other dosing schemes. This work will satisfy the dosing information needs of busy physicians involved in pharmacotherapy for patients with kidney disease, as well as pharmacists, nurses and students
|